Keyphrases
Asthma
95%
Severe Asthma
28%
Poorly Controlled Asthma
25%
Asthma Treatment
24%
Inhaled Corticosteroids
24%
World Trade Center
21%
Lung Function
21%
Asthma Control
19%
Placebo
18%
Respiratory Symptoms
17%
World Trade Center Dust
17%
Step-down
15%
Urban Population
15%
Asthma Exacerbation
15%
COVID-19
14%
Asthma Diagnosis
14%
Forced Expiratory Volume in 1 Second (FEV1)
14%
Confidence Interval
13%
Risk Factors
13%
Oral Corticosteroids
12%
Bronchodilator
12%
Spirometry
12%
Airway Obstruction
12%
Gastroesophageal Reflux
11%
Corticosteroids
11%
Long-acting beta-agonists
11%
Residential Community
11%
Lung
11%
Fume
11%
New Onset
10%
Asthma in the Elderly
10%
Respiratory Health
10%
Randomized Clinical Trial
10%
Work Community
10%
New York City
9%
Asthma Symptoms
9%
Mobile Health Studies
8%
Particulate Matter 2.5 (PM2.5)
8%
Clinical Outcomes
8%
Asthma Phenotypes
7%
Treatment Failure
7%
Smartphone
7%
Cough
7%
Comorbidity
7%
Corticosteroid Use
7%
Pulmonary Function
7%
Cleanup Workers
7%
Macrophages
7%
Well-controlled Asthma
6%
Severe Disease
6%
Medicine and Dentistry
Asthma
100%
Lung
32%
Placebo
17%
Bronchodilating Agent
17%
Severe Asthma
16%
Spirometry
15%
Gastroesophageal Reflux
13%
Patient with Asthma
13%
Beta Adrenergic Receptor Stimulating Agent
11%
Airway Obstruction
11%
Adolescence
10%
COVID-19
10%
Randomized Clinical Trial
10%
Forced Expiratory Volume
8%
Biological Marker
7%
Lung Function
7%
Chronic Obstructive Pulmonary Disease
6%
Disease
6%
Clinical Trial
6%
Eosinophil
6%
Treatment of Asthma
6%
Asthma Exacerbation
6%
Eosinophilic
5%
Dyspnea
5%
Coughing
5%
Drug Therapy
5%
Comorbidity
5%
Respiratory Disease
5%
Nitric Oxide
5%
Observational Study
5%
Omalizumab
5%
Esomeprazole
5%
Electronic Health Record
5%
Respiratory Tract Infection
5%
Tomography
5%
Dupilumab
5%
Wheeze
5%
Mobile Health
5%
Electronic Patient Record
5%
Peak Expiratory Flow
5%
Respiratory Tract Inflammation
5%
Eosinophilia
5%
Sensitization
5%
Emergency Department
5%
Global Health
5%
Lebrikizumab
5%
Infection
5%
Obstructive Sleep Apnea
5%
Lung Function Test
5%
Benralizumab
5%
